1. Signaling Pathways
  2. GPCR/G Protein
    Neuronal Signaling
  3. Cannabinoid Receptor
  4. CB1 Isoform
  5. CB1 Agonist

CB1 Agonist

CB1 Agonists (24):

Cat. No. Product Name Effect Purity
  • HY-152254
    CB2R/FAAH modulator-3
    Agonist 99.71%
    CB2R/FAAH modulator-3 (compound 27) is a dual targeting modulator that acts as a CB2R agonist and FAAH inhibitor.
  • HY-152253
    CB2R/FAAH modulator-2
    CB2R/FAAH modulator-2 (compound 26) is a dual targeting modulator that acts as a CB2R agonist and FAAH inhibitor.
  • HY-100488
    Bay 59-3074
    Agonist 99.00%
    Bay 59-3074 is a selective cannabinoid CB1/CB2 receptor partial agonist with Ki values of 48.3 and 45.5 nM at human CB1 and CB2 receptors, respectively.
  • HY-110028
    Leelamine hydrochloride
    Agonist 98.10%
    Leelamine hydrochloride is a tricyclic diterpene molecule that is extracted from the bark of pine trees.
  • HY-W005629
    Agonist 98.36%
    Leelamine is a weak agonist of cannabinoid receptors CB1 and CB2.
  • HY-P1397A
    RVD-Hpα TFA
    Agonist 98.99%
    RVD-Hpα TFA is the N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist.
  • HY-113689
    Agonist 99.98%
    GAT211 is a cannabinoid 1 receptor (CB1R) positive allosteric modulator (PAM).
  • HY-110014
    Noladin ether
    Agonist ≥98.0%
    Noladin ether is a potent and selective agonist of cannabinoid CB1 receptor, with a Ki of 21.2 nM.
  • HY-150029
    CB1/2 agonist 3
    CB1/2 agonist 3 (compound 52), a potent non-selective cannabinoid ligand, is a CB1/CB2 (cannabinoid receptor) competitive agonist.
  • HY-110036
    Agonist 99.12%
    GW-405833 (L768242) is a potent, selective cannabinoid receptor 2 (CB2) agonist with an EC50 of 50.7 nM.
  • HY-116637
    Agonist 99.79%
    Tetrahydromagnolol (Magnolignan), a main metabolite of Magnolol, is a potent and selective cannabinoid CB2 receptor agonist with an EC50 of 170 nM and a Ki of 416 nM.
  • HY-119104
    Agonist 99.45%
    AZD1940 is an orally active, high affinity cannabinoid CB1/CB2 receptor agonist with pKi values of 7.93 and 9.06 for human CB1R and CB2R, respectively.
  • HY-147512
    CB1/2 agonist 1
    CB1/2 agonist 1 is a potent and cross the blood-brain barrier CB1/2 agonist with EC50s of 56.15, 11.63 nM for CB1R and CB2R, respectively.
  • HY-112707
    AM9405 is a novel peripherally active cannabinoid type 1 (CB1) and serotonin type 3 receptor agonist.
  • HY-119744
    BAY 38-7271
    BAY 38-7271 is selective and highly potent and cannabinoid CB1/CB2 receptor agonist, with Kis of 1.85 nM and 5.96 nM for recombinant human CB1 receptor and CB2 receptor, respectively.
  • HY-151107
    CBR Agonist-2
    CBR Agonist-2 is a CB1 agonist (CB1R; CB1 ligand) with an EC50 and a Ki of 960 nM and 970 nM, respectively.
  • HY-150067
    CB1R antagonist 1
    CB1R Allosteric modulator 5, a selective cannabinoid-1 receptor (CB1R) inverse agonist with an IC50 value of 4.2 μM and EC50 value of >10 μM.
  • HY-12095
    CB1 inverse agonist 2
    CB1 inverse agonist 2 is an orally active inverse agonist of Cannabinoid Receptor CB1.
  • HY-W013788
    Agonist ≥99.0%
    2-Palmitoylglycerol (2-Palm-Gl), an congener of 2-arachidonoylglycerol (2-AG), is a modest cannabinoid receptor CB1 agonist.
  • HY-152251
    CB2R/FAAH modulator-1
    CB2R/FAAH modulator-1 is a cannabinoid type 2 receptor (CB2R) full agonist with Kis of 14.8 nM and 241.3 nM for CB2R and CB1R, respectively.